knowledge -WSS

knowledge

author：fashion 2025-08-12 11:29:42 - browse：8

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： IRA could hurt research into orphan drugs for rare diseases

WSS

Food makers tried to stack nutrition panel with preferred experts

Generate Biomedicines machine learning biotech raises $273M

Boston competes with Raleigh

Why you shouldn’t ask, “What country has the best health care?”

Private equity could exacerbate cardiology's overuse problem, experts fear

PEPFAR is under serious threat — and so is global health

knowledge

knowledge

entertainment

In age of alternative facts, a scholarly course on calling out crap

White House touts steps to stem shortages of cancer treatments

Tori Bowie and the unacceptable rates of Black maternal death

Wegovy leads to weight loss. Can it treat depression, too?

Heart attack and stroke risk calculators need revising

Telehealth for opioid use disorder is lifesaving

Novavax promises a turnaround & Lilly roils the obesity market

Hospitals consider fixing cancer drug shortages on their own

Sports medicine is finally prioritizing gender equality

Venture capital firm's plans to take over Akron hospital face hurdles

hotspot

Venture capital firm's plans to take over Akron hospital face hurdles

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

New Covid vaccine is recommended for everyone 6 months or older

PEPFAR is under serious threat — and so is global health

Diverse clinical trials: Why aren’t we there yet?

How generative AI ratchets up security threats for health systems

Wikipedia

Wikipedia

explore

knowledge